We usually don’t think too much about our kidneys, despite the hard job they do for us, cleaning our blood by removing toxins and waste materials. Genetic issues, injuries, some medicines or other factors can lead to kidney diseases that prevent these organs from functioning correctly. Common kidney problems are chronic kidney disease or acute kidney injury, but also infections, cysts, stones, and cancer. When kidneys fail completely, a dialysis or a kidney transplant are required. In the United States, kidney diseases are the ninth cause of death, which certainly puts them in the spotlight and makes the kidneys and their functioning subjects to various studies.

Research shows that cannabis might become a safer alternative to anti-inflammatory drugs and opioids prescribed to relieve pain in chronic kidney disease. A better understanding of the impact of cannabinoids on the renal system may lead to the development of new drugs that could treat the symptoms of kidney diseases with very little side effects compared to drugs available today.


The main components of the urinary system are kidneys, ureters, bladder, and the urethra. This system eliminates waste from the body, it contributes to regulating blood volume and blood pressure, controls electrolytes and metabolites, and regulates blood acidity. Kidneys have an intense blood circulation and inside them there are many tiny structures called nephrons, filtering our blood at the pace of half a cup every minute. Urine is formed as a result of this healthy filtration, and is passed to the bladder for a temporary storage. Only a small percentage of filtered blood becomes urine, while the purified water is returned to the blood flow, together with other useful substances. Kidneys constantly clean our blood of toxins, and they also maintain a healthy balance of water and minerals, such as sodium, calcium, phosphorus, and potassium. Finally, they produce hormones which control blood pressure, develop red blood cells and play a role in vitamin D absorption.


Most kidney diseases attack the nephrons. The acute kidney injury (AKI) is a sudden loss of kidney function that is observed over a course of a few days. This disease leads to complications like acidosis, excess of potassium, uremia, and may have dangerous effects on other organs. Mortality after a severe kidney injury remains high.

In chronic kidney disease (CKD) the damage usually happens slowly, over a long period of time, without making the patient feel sick until the condition becomes serious. The most common causes include diabetes and high blood pressure, while complications include heart disease, bone disease, and anaemia. Common symptoms are: leg swelling, vomiting, loss of appetite and energy, or even mental confusion.


Cannabinoid receptors CB1 and CB2 are found in various tissues and organs, including the kidneys. Endocannabinoid system regulates cell signalling targets that are vital for energy homeostasis. Experimental studies suggest that cannabinoids could have both beneficial and undesirable effects on the kidneys, depending on the type of renal disease, dosage and other factors. Research hasn’t fully explained how the endocannabinoid system might be involved in the development of renal conditions, or in the healing process. However, unbalanced endocannabinoid production—overactivation on CB1 and inhibition of CB2—appears to play a role in chronic kidney disease. This kind of imbalance is similar to the one happening in obesity and type II diabetes.



A study published in The American Journal of Medicine collected data from 14.000 adults who took part in the US National Health and Nutrition Examination Survey. Researchers checked levels of albumin in urine, which is a marker for kidney diseases, and they found no association between past or current marijuana use and worsened kidney function or disease. That’s good news for sure, yet a research at the Icahn School of Medicine at Mount Sinai in New York studying kidney disease in cannabis users found that chronic kidney disease (CKD) patients had kidney functions declining faster compared to those who did not use cannabis. However, this result could possibly be more related to the smoke inhalation than to the effects of THC or other cannabinoids.


Patients with advanced chronic kidney disease experience various symptoms, such as nausea, anorexia, chronic pain, insomnia. The adverse effects of often prescribed opioids are particularly strong in chronic kidney disease patients since they can increase the severity of those symptoms. The limited treatment options actually increase the demand for therapeutic alternatives, but many patients choose not to wait for the development of an approved cannabis therapy and start experimenting with medical cannabis for symptom management[1]. Nevertheless, even if medical cannabis has been used in many therapeutic applications, the evidence of its efficacy with chronic kidney disease has not been well reviewed, and not enough literature has been accumulated in order to advise properly on assumption forms and dosage.



Even if little research is available to-date, not only patients but also the scientific community started to seriously consider cannabinoids[2] as agents against symptoms of chronic kidney disease. The combination of therapeutic value and virtually no side effects put CBD under the nephrology research lens, particularly after CBD has been reported helpful in improving the symptoms of severe kidney condition in many self-medicating patients.

A study found that CBD reduces the toxic burden on kidneys[3] caused by chemotherapy. Nephrotoxicity is a common adverse effect of the potent chemotherapy agent cisplatin, thus the oxidative and nitrosative stress limits its clinical use. Treatment of mice with cannabidiol attenuated the cellular stress, the inflammation, and cell death in the kidney caused by cisplatin, greatly improving the renal function. The results of this study suggest that CBD may act against cisplatin-induced nephrotoxicity. And of course that CBD deserves more research in this area.


Cannabis has very few side effects on our organs and there is no risk of a cannabinoid overdose damaging our kidneys, yet patients with kidney diseases should be particularly careful in starting alternative therapeutic regimes, and they should discuss all the supplements they take with an informed healthcare specialist. Improvements in kidney disease symptoms with the assumption of CBD and/or THC might be real and should be clinically considered, as long as these or other supplements don’t interact with prescribed drugs, and remembering that vaporization or edibles eliminate the harms related to smoking.

External Resources:
  1. A Review of Cannabis in Chronic Kidney Disease Symptom Management https://www.ncbi.nlm.nih.gov
  2. Is there a legitimate role for the therapeutic use of cannabinoids for symptom management in chronic kidney disease? - PubMed - NCBI https://www.ncbi.nlm.nih.gov
  3. Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death. - PubMed - NCBI https://www.ncbi.nlm.nih.gov
This content is for educational purposes only. The information provided is derived from research gathered from external sources.

Are you aged 18 or over?

The content on RoyalQueenSeeds.com is only suitable for adults and is reserved for those of legal age.

Ensure you are aware of the laws of your country.

By clicking ENTER, you confirm
you are
18 years or older